Amidst the recent heightened volatility in artificial intelligence (AI) concept stocks, Wall Street investors are now repositioning themselves in the healthcare sector. Analysts believe that the aging population driving healthcare demand, improved corporate profit prospects, and relatively low valuations have made healthcare stocks an important direction for recent fund reallocations.
In recent years, healthcare stocks have lagged behind the overall market performance, but market expectations are gradually improving. With the aging population continuing to drive demand for medical services and revenue growth being fueled by new products such as weight-loss drugs and cancer treatments, multiple investment institutions anticipate that healthcare companies’ profits will resume double-digit growth from the fourth quarter of this year, indicating a strengthening fundamental outlook for the sector.
Market data also reflects a shift in investor sentiment. According to statistics from the London Stock Exchange Group (LSEG), the S&P 500 healthcare index has risen by 11.2% in the past three months, outperforming the S&P 500 index, which saw a gain of approximately 6% during the same period. The healthcare sector is trading at a price-to-earnings ratio of around 18 times, lower than the technology sector at approximately 30 times, making valuation advantage a key factor attracting funds.
As reported by Reuters, Dan Lyons, the portfolio manager at Janus Henderson Investors, stated that the healthcare sector still holds attractive valuations and is poised to attract more funds for reallocation amid improved profit expectations. He emphasized that the healthcare industry combines both growth potential and defensive characteristics, especially with the continuous increase in healthcare demand driven by the aging population, making it a favorable long-term prospect in the market.
In addition to the improving fundamentals, corporate performances have further boosted market confidence. In recent times, several healthcare companies such as AbbVie and UnitedHealth Group have reported financial results that surpass market expectations. Mergers and acquisitions activity in the healthcare industry has also been on the rise, with total deal value nearing $284 billion so far this year, nearly matching the level for the entire previous year, indicating continued optimism towards the industry’s outlook.
On the other hand, AI concept tech stocks, which have been leading the U.S. stock market rally this year, experienced significant fluctuations during the earnings season. As a result, some investors have started adjusting their portfolio allocations, redirecting funds towards the healthcare sector, which offers lower valuations and relatively stable performance. Market experts believe that this fund rotation does not signify a bearish sentiment towards tech stocks but rather reflects a search for investment targets that combine defensive and growth characteristics in a high valuation environment.
Some Wall Street institutions have indicated that aside from the long-term demand brought by the aging population, potential adjustments in healthcare policies following the U.S. midterm elections in November are also a focal point of ongoing market scrutiny. Changes in the policy environment could impact the operational prospects of insurance companies, hospital operators, and certain healthcare service providers, potentially becoming a key area of market observation in the next phase.